UCB Pharma S.A.

Form 483

Braine-L'Alleud, -, BelgiumFEI 3003909356Issued February 04, 2022

View Form 483 PDF

Source: FDA, document on file. FDA released the Form 483 itself. The document linked above is our copy of FDA's file, stored by us so the link cannot break, and FDA's own copy is linked beside it. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3003909356.

Observations4

Issue DateFebruary 04, 2022

StatusNo Warning Letter

Related Inspections8

Establishment Details

Firm: UCB Pharma S.A.
Location: Braine-L'Alleud, -, Belgium
FEI Number: 3003909356
Product Type: Drugs
Issue Date: February 04, 2022
Country: Belgium

Inspection History, 2011 to 2026

NAI3

VAI5

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

UCB Pharma S.A. FDA Form 483, Braine-L'Alleud, February 4, 2022